- Home
- SGMO vs PCF Comparison
SGMO vs PCF Comparison
Compare SGMO & PCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- PCF
- Stock Information
- Founded
- SGMO 1995
- PCF 1987
- Country
- SGMO United States
- PCF United States
- Employees
- SGMO N/A
- PCF N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- PCF Trusts Except Educational Religious and Charitable
- Sector
- SGMO Health Care
- PCF Finance
- Exchange
- SGMO Nasdaq
- PCF Nasdaq
- Market Cap
- SGMO 122.8M
- PCF 119.3M
- IPO Year
- SGMO 2000
- PCF N/A
- Fundamental
- Price
- SGMO $0.54
- PCF $6.35
- Analyst Decision
- SGMO Buy
- PCF
- Analyst Count
- SGMO 6
- PCF 0
- Target Price
- SGMO $4.50
- PCF N/A
- AVG Volume (30 Days)
- SGMO 5.7M
- PCF 74.8K
- Earning Date
- SGMO 08-12-2025
- PCF 01-01-0001
- Dividend Yield
- SGMO N/A
- PCF 10.90%
- EPS Growth
- SGMO N/A
- PCF N/A
- EPS
- SGMO N/A
- PCF N/A
- Revenue
- SGMO $63,756,000.00
- PCF N/A
- Revenue This Year
- SGMO $1.29
- PCF N/A
- Revenue Next Year
- SGMO $1.60
- PCF N/A
- P/E Ratio
- SGMO N/A
- PCF N/A
- Revenue Growth
- SGMO 239.92
- PCF N/A
- 52 Week Low
- SGMO $0.41
- PCF $5.71
- 52 Week High
- SGMO $3.18
- PCF $6.96
- Technical
- Relative Strength Index (RSI)
- SGMO 50.80
- PCF 46.79
- Support Level
- SGMO $0.50
- PCF $6.28
- Resistance Level
- SGMO $0.70
- PCF $6.45
- Average True Range (ATR)
- SGMO 0.05
- PCF 0.03
- MACD
- SGMO 0.01
- PCF -0.01
- Stochastic Oscillator
- SGMO 29.17
- PCF 41.18
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About PCF High Income Securities Fund
High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective primarily by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.